Patents Assigned to NANJING SHIHE GENE BIOTECHNOLOGY CO., LTD.
  • Publication number: 20220186322
    Abstract: The present invention relates to a field of medical molecular biology, and in particular, a marker for homologous recombination deficiency (HRD), a method and a system for detection thereof. In the present invention, the genome-wide single nucleotide polymorphisms (SNPs) with a high heterozygous rate suitable for the Chinese population are provided by screening SNP sites on the gnomAD records and over 300 Chinese whole-genome sequencing (WGS) data, thereby establishing a HRD scoring method. The HRD markers provided by the present invention allow HRD to be effectively scored, having a calculation result in high consistent with the WGS result.
    Type: Application
    Filed: March 4, 2022
    Publication date: June 16, 2022
    Applicant: NANJING SHIHE GENE BIOTECHNOLOGY CO.,LTD.
    Inventors: Chenglong NA, Yang SHAO, Hua BAO, Rui LIU, Shuyu WU, Yi SHEN, Xiaonan WANG, Xue WU
  • Patent number: 10998084
    Abstract: A sequencing data analysis method, a device and a computer-readable medium for microsatellite instability. The present invention can use NGS sequencing results to determine whether the microsatellite instability is present. The sequencing data analysis method can significantly improve detection sensitivity without reducing specificity, and can quickly and automatically evaluate a stable or unstable status of each MSI locus with high throughput, high sensitivity, and high specificity. By combining the statuses for all MSI loci in each sample, the samples can be comprehensively evaluated as MSS, MSI-L, or MSI-H.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: May 4, 2021
    Assignee: NANJING SHIHE GENE BIOTECHNOLOGY CO., LTD.
    Inventors: Yang Shao, Xue Wu, Zhili Chang, Xiaonan Wang, Chongguang Yan, Shuyu Wu, Hua Bao, Xiaoling Tong